By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

FermaVir Pharmaceuticals, Inc. 

420 Lexington Avenue

New York  New York  10170  U.S.A.
Phone: 212-375-2630 Fax:


SEARCH JOBS








Company News
Shareholders Approve Inhibetex Therapeutics Inc. Acquisition of FermaVir Pharmaceuticals, Inc. (FMVR.OB) 9/20/2007 9:43:23 AM
Preclinical Data on FermaVir Pharmaceuticals, Inc. (FMVR.OB)'s FV-100 Presented at the 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy 9/19/2007 10:48:42 AM
FermaVir Pharmaceuticals, Inc. (FMVR.OB) Announces Positive Data from Recent Preclinical Studies of FV-100 8/8/2007 1:38:31 PM
The Day In Review: Entereg from GlaxoSmithKline (GSK) and Adolor Corporation (ADLR) Fails Test 4/10/2007 5:45:55 PM
Inhibitex, Inc. (INHX) to Acquire FermaVir Pharmaceuticals, Inc. (FMVR.OB) for $19 Million in Stock 4/10/2007 8:50:40 AM
FermaVir Pharmaceuticals, Inc. (FMVR.OB) CEO Featured in Exclusive Interview With WallSt.net 3/7/2007 11:09:47 AM
RAB Capital Fund Raises Its Stake To 8.3% In FermaVir Pharmaceuticals, Inc. (FMVR.OB) 2/15/2007 12:22:17 PM
FermaVir Pharmaceuticals, Inc. (FMVR.OB) Closes $1.27 Million Financing 1/16/2007 11:36:14 AM
FermaVir Pharmaceuticals, Inc. (FMVR.OB)'s Founder And Board Member Professor Chris McGuigan Receives The Royal Society Of Chemistry's Award For Medicinal Chemistry 11/15/2006 11:19:00 AM
FermaVir Pharmaceuticals, Inc. (FMVR.OB) Announces New Preclinical Data For FV-100, Its Clinical Candidate For Shingles; Recent Data Shows Excellent Penetration And Viral Inhibition By FV-100 In Cells 8/30/2006 11:05:17 AM
12
//-->